DELTEX
Live / Allowed — Notice of allowance issued (as of 25 Nov 2025)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 03 Jan 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 98936412
- Mark type
- Stylized text
- Filed
- 03 Jan 2025
- Published for opposition
- 30 Sept 2025
- Attorney of record
- Mark A. Jansen
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals in the nature of cell therapeutics for the treatment and prevention of cancer; engineered cell therapies, namely, engineered T cells, immune cells, and antibodies for the treatment and prevention of cancer
- Class 042 — Scientific and technological services: Medical research and development; Research and development of pharmaceuticals; Research and development in the field of bioengineering and genetic engineering; Research and development of treatments and therapies in the field of oncology; Research and development of pharmaceuticals for the treatment and prevention of cancer, autoimmune, inflammatory, and infectious diseases and disorders; Scientific research for medical purposes in the field of cancer, autoimmune, inflammatory, and infectious diseases and disorders; Scientific research and development in the field of molecules, cells, and genetics; Scientific development of processes and methods for the manufacturing and engineering of cells and molecules; Pharmaceutical development of therapeutics and treatments for the prevention of cancer, autoimmune, inflammatory, genetic and infectious diseases and disorders
- Class 044 — Medical, beauty and agricultural services: Medical services; Providing health information; Providing health information in the field of bioengineering and genetic engineering; Providing health information in the field of autoimmune, inflammatory and infectious diseases and disorders, cancer prevention and treatment; Medical diagnosis and treatment of cancer, autoimmune, inflammatory, and infectious diseases and disorders
Owner
- In8bio, Inc., New York, NY, US
- In8bio, Inc., New York, NY, US
Prosecution history
- 25 Nov 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 30 Sept 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 30 Sept 2025 — PUBLISHED FOR OPPOSITION
- 24 Sept 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 02 Sept 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 02 Sept 2025 — EXAMINER'S AMENDMENT ENTERED
- 02 Sept 2025 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 02 Sept 2025 — EXAMINERS AMENDMENT E-MAILED
- 02 Sept 2025 — EXAMINERS AMENDMENT -WRITTEN
- 15 Jun 2025 — ASSIGNED TO EXAMINER
- 28 Apr 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 03 Jan 2025 — NEW APPLICATION ENTERED